US Tariffs Threaten German Pharma
Pharma Germany criticizes Donald Trump’s planned 100% tariffs on medicines as a massive attack on trade and supply security. Europe must act now.
AAA-Pharma goes yellow: New brand identity launched
AAA-Pharma launches its new brand identity: Yellow as the core color, a digital relaunch of the website, and a strong commitment to the German pharmaceutical market.
Bayer opens new lab for phytomedicine
Bayer invests in the future of phytomedicine: a new lab for plant-based health products has been inaugurated in Darmstadt.
Day of Innovative Healthcare Economy 2025 in Berlin
At the “Day of Innovative Healthcare Economy 2025” in Berlin, 320 guests discussed bureaucracy reduction, digitalization and the role of AI for Germany’s industrial competitiveness.
Federal government should relieve health insurers of citizens’ benefit contributions
The German Medical Association calls on the federal government to fully cover health insurance contributions for citizens’ benefit recipients to stabilize the healthcare system.
Pfizer to Acquire Metsera for $4.9 Billion
Pfizer is acquiring Metsera for $4.9 billion, securing a portfolio of next-generation obesity therapies. The deal could reshape the market for cardiometabolic diseases.
New Brand Strengthens Public Health Service
With the new brand “Der ÖGD – Protects. Helps. Explains.”, federal and state governments highlight the indispensable work of public health offices. A nationwide campaign informs citizens.
Pharmacists favor cold remedies
The new Bonsai OTC Category Spotlight shows: Cold remedies are the clear No. 1 in German pharmacies – and pharmacists’ enjoyment of consultations is rising.
Golden Leaf Gala in Cologne: Premiere for Medical Cannabis
On October 31, 2024, the “Golden Leaf Gala” will premiere in Cologne – an exclusive event putting medical cannabis in the spotlight and uniting industry pioneers.
Expopharm 2025 kicks off in Düsseldorf
On September 17, 2025, Expopharm opens its doors in Düsseldorf: Europe’s largest pharmacy industry gathering with top exhibitors, 200 speakers and practice-oriented sessions.
COMPRIX 2026: Call for Entries Open
COMPRIX 2026 has started: From November 3, creative healthcare projects can be submitted – now also in the brand-new “Health Design” category.
Fresenius secures €400 million loan from EIB
The EIB provides Fresenius with a €400 million loan to strengthen research, innovation, and biosimilar production in Europe.
Flu Vaccination in Pharmacies Secured Long-Term
Starting October 15, 2025, pharmacies will permanently offer flu vaccinations. Pharma Germany sees this as a key step for prevention and public health.
B2B Marketing Budgets 2025 Under Pressure
The new bvik study reveals: B2B marketing budgets are declining in 2025 for the first time in five years. Still, companies are focusing on lead generation, digital infrastructure, and marketing automation.
Pharmaceutical Industry Remains Top Employer in Germany
Despite economic uncertainties, the pharmaceutical sector remains one of Germany’s most attractive employers. A recent survey shows: 76.5% rate the industry as attractive.
What truly makes the difference here?
AstraZeneca Germany has launched a new employer branding campaign where employees openly share how their work makes a difference for them and for society.
ABDA at expopharm 2025: Strong Presence in Düsseldorf
expopharm 2025 in Düsseldorf features numerous events with ABDA participation – from pharmaceutical services to key questions on the future of healthcare.
Lilly builds multi-billion-dollar site in Alzey
Eli Lilly is investing $2.5 billion in a new production site in Alzey, Germany. The facility will create up to 1,000 new jobs in the pharmaceutical industry.
The New Power of Routines
Personal care is more than cosmetics – it’s becoming a global foundation for health, well-being, and prevention. A new study reveals how routines are changing lives.
100 days of ePA: Awareness stagnates, usage remains low
100 days after its launch, Germany’s electronic health record (ePA) is only used by a small number of insured persons. Technical barriers and lack of information slow down progress.